Clinical Trials Lotemax® Gel 0.5% and Restasis 0.05% in Subjects With Mild or Moderate Keratoconjunctivitis Sicca by ClinicalTrialsFeed • 2013/03/22 • 0 Comments Status: Not yet recruiting, Condition Summary: Keratoconjunctivitis Sicca